Clinical Trials Directory

Trials / Unknown

UnknownNCT03665467

The Global Prevalence of Infections in Urology Study

Status
Unknown
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
European Association of Urology Research Foundation · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Urology departments from all over the world are invited to join the Global Prevalence Study on Infections in Urology (GPIU-study) and the GPIU Prostate Biopsy Side Study. The GPIU study is taking part annually in November since 2003. European urologists were the first group of specialist to register hospital acquired infections on an international level. More than 20.000 patients have been screened and more than 2000 patients are currently listed in this database. Why? Infectious complications after urological procedures, such as prostate biopsy and increasing antimicrobial resistance are posing significant threats to modern urology The GPIU-study is a combined quality improvement initiative and a scientific study. Once the participating departments have filled in the report forms they will get access to statistics showing the accumulated results for all participating hospitals. The participants can anonymously compare their own results with hospitals from all over the World. The GPIU-study application has been designed as an instrument to ongoing follow-up of the development of important factors related to infection on international, national and local levels. Take responsibility for the future of urology - join the GPIU-studies! http://gpiu.esiu.org Prof. Dr. Florian M.E. Wagenlehner, MD, PhD Clinic for Urology, Pediatric Urology and Andrology University Clinic Giessen, Germany GPIU study coordinator Prof. Truls E. Bjerklund Johansen, MD, PhD Urology Department, Oslo University Hospital, Chairman ESIU Oslo, NO GPIU Study coordinator Zafer Tandogdu University College London (UCL), UK Dominic Althaus Software engineer Giessen, Ger

Conditions

Timeline

Start date
2003-11-30
Primary completion
2021-01-31
Completion
2021-12-31
First posted
2018-09-11
Last updated
2021-02-04

Locations

4 sites across 4 countries: Germany, Hungary, Norway, United Kingdom

Source: ClinicalTrials.gov record NCT03665467. Inclusion in this directory is not an endorsement.